<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Head and Neck Tumors</journal-id><journal-title-group><journal-title xml:lang="en">Head and Neck Tumors</journal-title><trans-title-group xml:lang="ru"><trans-title>Опухоли головы и шеи</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2222-1468</issn><issn publication-format="electronic">2411-4634</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">565</article-id><article-id pub-id-type="doi">10.17650/2222-1468-2020-10-3-90-96</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОРНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Head and neck tumors and assisted reproductive technologies: social and legal aspects</article-title><trans-title-group xml:lang="ru"><trans-title>Опухоли головы и шеи и вспомогательные репродуктивные технологии: социально-правовой аспект</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4045-1247</contrib-id><name-alternatives><name xml:lang="en"><surname>Ognerubov</surname><given-names>N. A.</given-names></name><name xml:lang="ru"><surname>Огнерубов</surname><given-names>Н. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>93 Sovetskaya St., Tambov 392000</italic></p></bio><bio xml:lang="ru"><p><bold>Николай Алексеевич Огнерубов </bold></p><p><italic>392000 Тамбов, ул. Советская, 93 </italic></p></bio><email>ognerubov_n.a@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">G.R. Derzhavin Tambov State University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Тамбовский государственный университет им. Г.Р. Державина»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-11-16" publication-format="electronic"><day>16</day><month>11</month><year>2020</year></pub-date><volume>10</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>90</fpage><lpage>96</lpage><history><date date-type="received" iso-8601-date="2020-11-16"><day>16</day><month>11</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-11-16"><day>16</day><month>11</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, Ognerubov N.A.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, Огнерубов Н.А.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">Ognerubov N.A.</copyright-holder><copyright-holder xml:lang="ru">Огнерубов Н.А.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://ogsh.abvpress.ru/jour/article/view/565">https://ogsh.abvpress.ru/jour/article/view/565</self-uri><abstract xml:lang="en"><p><bold>Background</bold>. Currently, the proportion of pregnancies obtained by assisted reproductive technologies (ARTs) reaches 1.7–4.0 %. Short-term and long-term results of ART implementation require public and, most importantly, legal assessment. Some publications suggest higher risks of congenital deformities and head and neck cancers in children conceived by ART.</p><p><bold>Objective</bold>: to review publications analyzing the problem of head and neck cancers in children conceived by ART and legal protection of the embryo.</p><p><bold>Materials and methods</bold>. We performed retrospective analysis of 42 articles published in 1995–2019, including 33 foreign and 9 Russian articles.</p><p><bold>Results</bold>. Earlier studies have demonstrated that children conceived by ART have an increased risk of cancers, including head and neck cancers, such as central nervous system tumors and retinoblastoma. Recent publications have shown no significant differences in the prevalence of malignant tumors between children born after ART and children conceived naturally. Nevertheless, the risk of developing head and neck tumors is higher in children after ART. The analysis of Russian and international legislation has demonstrated that the legal status of an embryo differs depending on whether it develops in vivo or in vitro.</p><p><bold>Conclusion</bold>. Children conceived by ART are at higher risk of malignant head and neck tumors, primarily central nervous system tumors and retinoblastoma. The legal status of an embryo depends on whether it develops in vivo or in vitro.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Введение</bold>. В настоящее время на долю беременностей, ставших результатом применения вспомогательных репродуктивных технологий (ВРТ), приходится 1,7–4,0 %. Непосредственные и отдаленные результаты внедрения ВРТ требуют общественной и, что особенно важно, правовой оценки. Данные литературы свидетельствуют о риске развития у детей, зачатых с помощью ВРТ, как врожденных уродств, так и злокачественных опухолей головы и шеи.</p><p><bold>Цель исследования</bold> – изучить данные научной литературы по проблеме возникновения злокачественных опухолей головы и шеи у детей, зачатых с помощью ВРТ, и по вопросу о правовой охране эмбриона.</p><p><bold>Материалы и методы</bold>. Проведен ретроспективный анализ данных 42 источников, опубликованных в 1995–2019 гг., из них 33 иностранных и 9 русскоязычных.</p><p><bold>Результаты</bold>. Более ранние исследования свидетельствуют о наличии у детей, зачатых с помощью ВРТ, повышенного риска возникновения раковых опухолей, в том числе в области головы и шеи – опухолей центральной нервной системы и ретинобластом. В недавних публикациях сообщается об отсутствии статистически значимых различий в распространенности злокачественных опухолей среди детей, рожденных с помощью ВРТ и зачатых естественным путем. Тем не менее риск развития опухолей головы и шеи у зачатых путем экстракорпорального оплодотворения выше. Анализ российского и международного законодательства показал, что правой статус эмбриона рассматривается по-разному в зависимости от того, развивается он in vivo или in vitro.</p><p><bold>Заключение</bold>. Дети, зачатые с помощью ВРТ, имеют более высокий риск развития злокачественных опухолей головы и шеи, среди которых преобладают опухоли центральной нервной системы и ретинобластома. Правовой статус эмбриона отличается в зависимости от того, развивается он in vitro или in vivo.</p></trans-abstract><kwd-group xml:lang="en"><kwd>head and neck cancers</kwd><kwd>assisted reproductive technologies</kwd><kwd>human embryo</kwd><kwd>legal status</kwd><kwd>crimes</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>злокачественные опухоли головы и шеи</kwd><kwd>вспомогательные репродуктивные технологии</kwd><kwd>эмбрион человека</kwd><kwd>правовой статус</kwd><kwd>преступления</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Measurement assisted human reproduction outcomes in Canada. A discussion paper prepared for participants of the 2010 Outcomes Roundtable. http://publications.gc.ca/collections/collection_2011/pac-ahrc/H1.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Qin J., Sheng X., Wang H. et al. Assisted reproductive technology and risk of congenital malformations: a metaanalysis based on cohort studies. Arch Gynecol Obstet 2015;292(4):777–98. DOI: 10.1007/s00404-015-3707-0.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Simpson J.L. Birth defects and assisted reproductive technologies. Semin Fetal Neonatal Med 2014;19(3):177–82. DOI: 10.1016/j.siny.2014.01.001.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Sunderam S., Kissin D.M., Crawford S.B. et al. Assisted reproductive technology surveillance – United States, 2015. MMWR Surveill Summ 2018;67(3):1–28. DOI: 10.15585/mmwr.ss6703a1.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Fauser B.C., Devroey P., Diedrich K. et al. Evian Annual Reproduction (EVAR) Workshop Group 2011. Health outcomes of children born after IVF/ICSI: a review of current expert opinion and literature. Reprod Biomed Online 2014;28(2):162–82. DOI: 10.1016/j.rbmo.2013.10.013.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Gosden R., Trasler J., Lucifero D., Faddy M. Rare congenital disorders, imprinted genes, and assisted reproductive technology. Lancet 2003;361(9373):1975–7. DOI: 10.1016/S0140-6736(03)13592-1.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Källén B., Finnström O., Lindam A. et al. Congenital malformations in infants born after in vitro fertilization in Sweden. Birth Defects Res A Clin Mol Teratol 2010;88(3):137–43. DOI: 10.1002/bdra.20645.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Sutcliffe A.G., Ludwig M. Outcome of assisted reproduction. Lancet 2007;370(9584):351–9. DOI: 10.1016/S0140-6736(07)60456-5.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Davies M.J., Moore V.M., Willson K.J. et al. Reproductive technologies and the risk of birth defects. N Engl J Med 2012;366(19):1803–13. DOI: 10.1056/NEJMoa1008095.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Botto L.D., Flood T., Little J. et al. Cancer risk in children and adolescents with birth defects: a population-based cohort study. PLoS One 2013;8(7):e69077. DOI: 10.1371/journal.pone.0069077.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Katalinic A., Rösch C., Ludwig M. Pregnancy course and outcome after intracytoplasmic sperm injection: a controlled, prospective cohort study. Fertil Steril. 2004;81(6):1604–16. DOI: 10.1016/j.fertnstert.2003.10.053.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Harper J., Geraedts J., Borry P. et al. Current issues in medically assisted reproduction and genetics in europe: research, clinical practice, ethics, legal issues and policy. Hum Reprod 2014;29(8):1603–9. DOI: 10.1093/humrep/deu130.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Hansen M., Kurinczuk J.J., Bower C., Webb S. The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. N Engl J Med 2002;346(10):725–30. DOI: 10.1056/NEJMoa010035.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Hediger M.L., Bell E.M., Druschel C.M., Buck Louis G.M. Assisted reproductive technologies and children’s neurodevelopmental outcomes. Fertil Steril 2013;99(2):311–7. DOI: 10.1016/j.fertnstert.2012.12.013.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Hoorsan H., Mirmiran P., Chaichian S. et al. Congenital malformations in infants of mothers undergoing assisted reproductive technologies: a systematic review and meta-analysis study. J Prev Med Public Health 2017;50(6):347–60. DOI: 10.3961/jpmph.16.122.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Mayor S. Risk of congenital malformations in children born after assisted reproduction is higher than previously thought. BMJ 2010;340:c3191. DOI: 10.1136/bmj.c3191.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Neumann C., Thompson D.A., Thorson H. et al. Assisted reproduction is not associated with increased risk of congenital head and neck defects. Cureus 2018;10(3):e2287. DOI: 10.7759/cureus.2287.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Toren A., Sharon N., Mandel M. et al. Two embryonal cancers after in vitro fertilization. Cancer 1995;76(11):2372–4.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Hargreave M., Jensen A., Toender A. et al. Fertility treatment and childhood cancer risk: a systematic meta-analysis. Fertil Steril 2013;100(1):150–61. DOI: 10.1016/j.fertnstert.2013.03.017.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>White L., Giri N., Vowels M.R., Lancaster P.A. Neuroectodermal tumours in children born after assisted conception. Lancet 1990;336(8730):1577. DOI: 10.1016/0140-6736(90)93350-x.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Michalek A.M., Buck G.M., Nasca P.C. et al. Gravid health status, medication use, and risk of neuroblastoma. Am J Epidemiol 1996;143(10):996–1001. DOI: 10.1093/oxfordjournals.aje.a008682.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Olshan A.F., Smith J., Cook M.N. et al. Hormone and fertility drug use and the risk of neuroblastoma: a report from the Children’s Cancer Group and the Pediatric Oncology Group. Am J Epidemiol 1999;150(9):930–8. DOI: 10.1093/oxfordjournals.aje.a010101.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Brinton L.A., Kruger K.S., Thomsen B.L. et al. Childhood tumor risk after treatment with ovulation-stimulating drugs. Fertil Steril 2004;81(4):1083–91. DOI: 10.1016/j.fertnstert.2003.08.042.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Mallol-Mesnard N., Menegaux F., Lacour B. et al. Birth characteristics and childhood malignant central nervous sytem tumors: the ESCALE study (French Society for Childhood Cancer). Cancer Detect Prev 2008;32(1):79–86. DOI: 10.1016/j.cdp.2008.02.003.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Marees T., Dommering C.J., Imhof S.M. et al. Incidence of retinoblastoma in Dutch children conceived by IVF: an expanded study. Hum Reprod 2009;24(12):3220–4. DOI: 10.1093/humrep/dep335.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Källén B., Finnström O., Lindam A. et al. Cancer risk in children and young adults conceived by in vitro fertilization. Pediatrics 2010;126(2):270–6. DOI: 10.1542/peds.2009-3225.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Foix-L’Hélias L., Aerts I., Marchand L. et al. Are children born after infertility treatment at increased risk of retinoblastoma? Hum Reprod 2012;27(7):2186–92. DOI: 10.1093/humrep/des149.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Spaan M., van den Belt-Dusebout A.W., van den Heuvel-Eibrink M.M. et al. Risk of cancer in children and young adults conceived by assisted reproductive technology. Hum Reprod 2019;34(4):740–50. DOI: 10.1093/humrep/dey394.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Spector L.G., Brown M.B., Wantman E. et al. Association of in vitro fertilization with childhood cancer in the United States. JAMA Pediatr 2019;173(6):e190392. DOI: 10.1001/jamapediatrics.2019.0392.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Okun N., Sierra S. Pregnancy outcomes after assisted human reproduction. J Obstet Gynaecol Can 2014;36(1):64–83. DOI: 10.1016/S1701-2163(15)30685-X.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Ognerubov N.A. Оn the issue of criminal law protection of the right of an embryo to life in the context of determining the moment of its beginning. The Scientific Heritage 2018;(27):13–5.</mixed-citation></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">Pavlova Y.V., Dautbaeva-Mukhtarova A.E. Human life: the issue of determination of the start of legal protection. Meditsinskoe pravo = Journal of Medical Law 2018;(2):37–40. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Павлова Ю.В., Даутбаева-Мухтарова А.Е. Человеческая жизнь: проблема определения момента начала правовой охраны. Медицинское право 2018;(2):37–40.</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><citation-alternatives><mixed-citation xml:lang="en">Maleshina A.V. Prospects for the criminal protection of “potential human life” (the comparative analysis). Izvestiya vysshikh uchebnykh zavedeniy. Pravovedenie = News of higher educational institutions. Jurisprudence 2011;(3):132–52. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Малешина А.В. Перспективы и возможности уголовно-правовой охраны «будущей жизни» (сравнительно-правовой анализ). Известия высших учебных заведений. Правоведение 2011;(3):132–52.</mixed-citation></citation-alternatives></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">Druzhinina Yu. F. Legal regime of embryo in vitro. Zhurnal rossiyskogo prava = Journal of Russian Law 2017;(12):129–40. (In Russ.). DOI: 10.12737/article_5a200506899599.19842755.</mixed-citation><mixed-citation xml:lang="ru">Дружинина Ю.Ф. Правовой режим эмбриона in vitro. Журнал российского права 2017;(12):129–40. DOI: 10.12737/article_5a200506899599.19842755.</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">Samoilova V.V. Russian and foreign family legislation on the use of assisted reproductive technologies (ART). Semeynoe i zhilishchnoe pravo = Family and Housing Law 2010;(3):7–11. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Самойлова В.В. Российское и зарубежное семейное законодательство о применении вспомогательных репродуктивных технологий (ВРТ). Семейное и жилищное право 2010;(3):7–11.</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">Tishkevich I.S. Qualification of crimes against life. Minsk: PH of the MIA of the USSR, 1971. 78 p. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Тишкевич И.С. Квалификация преступлений против жизни. Минск: Изд-во МВШМ МВД СССР, 1971. 78 с.</mixed-citation></citation-alternatives></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">Kurguzkina E.B. Mother’s murder of a newborn: nature, causes, prevention. Voronezh: Institute of the MIA of Russia, 1999. 151 p. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Кургузкина Е.Б. Убийство матерью новорожденного: природа, причины, предупреждение. Воронеж: Институт МВД России, 1999. 151 с.</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><citation-alternatives><mixed-citation xml:lang="en">Saint-Rose J. Law and life. Vestnik Moskovskogo universiteta. Seriya 11. Pravo = Bulletin of the Moscow University. Series 11. Law 2003;(6):56–69. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Сэнт-Роз Ж. Право и жизнь. Вестник Московского университета. Серия 11. Право 2003;(6):56–69.</mixed-citation></citation-alternatives></ref><ref id="B39"><label>39.</label><mixed-citation>Mason &amp; McCall Smith’s Law and medical ethics. London, Edinburgh, Dublin: Butterworths, 1999. Pp. 125–37.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Moss K., Hughes R. Hart–Devlin revisited: law, morality and consent in parenthood. Med Sci Law 2011;51(2): 68–75. DOI: 10.1258/msl.2010.010214.</mixed-citation></ref></ref-list></back></article>
